Segment Information

6 Months Ended

Jun. 28, 2013

Segment Reporting, Measurement Disclosures [Abstract]

Segment Information

SEGMENT INFORMATION

The Company operates and reports its results in five separate business segments consisting of the Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental and Industrial Technologies segments. The Company’s equity in earnings of the Apex joint venture is shown separately in the Company’s segment disclosures. There has been no material change in total assets or liabilities by segment since December 31, 2012, except for the sale of the investment in the Apex joint venture in February 2013. Segment results are shown below ($ in millions):

Sales
	Three Months Ended				Six Months Ended
	June 28, 2013		June 29, 2012		June 28, 2013		June 29, 2012
Test & Measurement	$	855.0	$	856.4	$	1,710.4	$	1,702.8
Environmental	826.8		763.9		1,552.1		1,458.5
Life Sciences & Diagnostics	1,674.3		1,583.4		3,241.7		3,129.3
Dental	514.7		498.8		994.5		963.5
Industrial Technologies	866.7		851.0		1,683.5		1,615.6
	$	4,737.5	$	4,553.5	$	9,182.2	$	8,869.7

Operating Profit
	Three Months Ended						Six Months Ended
	June 28, 2013			June 29, 2012			June 28, 2013			June 29, 2012
Test & Measurement	$	178.4		$	184.2		$	365.7		$	375.8
Environmental	178.9			165.1			314.0			294.2
Life Sciences & Diagnostics	240.7			207.9			440.0			413.8
Dental	78.8			71.6			141.7			130.5
Industrial Technologies	204.1			190.3			375.0			348.1
Equity method earnings of Apex joint venture	—			18.0			—			32.4
Other	(37.3		)	(25.8		)	(61.9		)	(48.6		)
	$	843.6		$	811.3		$	1,574.5		$	1,546.2